Found 0 matching trials
Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - Tanzania NA The primary objective of the study is to demonstrate and quantify the prote...
Show More Location
Ifakara Health Institute
Learn More & Join Trial
A Study of HB-202/HB-201 With Pembrolizumab in Patients With HPV16+ Recurrent/Metastatic Oropharyngeal Cancer PHASE2 This is a study of HB-202/HB-201 alternating 2-vector therapy with pembroli...
Show More Location
Multiple Locations
Learn More & Join Trial
Gene-Modified Stem Cell Therapy for Children With Autosomal Recessive Osteopetrosis (ARO) PHASE1 This is a non-randomized, one-arm, open label, single-center, phase I/II, p...
Show More Location
Ospedale San Raffaele
Learn More & Join Trial
Safety and Efficacy of rAAV2tYF-GRK1-RPGR in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations PHASE1 This study will evaluate the safety and efficacy of a recombinant adeno-ass...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Safety and Efficacy of rAAV.hCNGA3 Gene Therapy in Patients With CNGA3-linked Achromatopsia PHASE1 The purpose of this study is to proof the safety and efficacy of a single b...
Show More Status
Active Not Recruiting
Location
University Hospital Tuebingen, Center for Ophthalmology
Learn More & Join Trial
A Phase 1, Open-label, Safety and Immunogenicity Study of an Oral Multi-dose Administration Regimen With an Adenoviral-vector Based Tablet Norovirus Vaccine (VXA-G1.1-NN) Administered to Healthy Adult Volunteers PHASE1 Subjects will receive multiple sub-doses over a 4-hour period to deliver a ...
Show More Learn More & Join Trial
A Clinical Trial to Determine the Safety and Immunogenicity of Healthy Candidate MERS-CoV Vaccine (MERS002) PHASE1 A phase Ib study to determine the safety and immunogenicity of the candidat...
Show More Location
King Abdulaziz Medical City, National Guard Health Affairs
Learn More & Join Trial
A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease PHASE1 The objectives of this clinical trial are to assess, for up to 5 years, the...
Show More Status
Active Not Recruiting
Location
UC Davis Medical Center
Learn More & Join Trial
International Multicenter Study of the Immunogenicity of Medicinal Product GamEvac-Combi PHASE4 The purpose of this study is to evaluate immunogenicity, epidemiological ef...
Show More Location
Centre de recherche en épidémiologie, microbiologie et de soins médicaux (CREMS) de Pastoria à Kindia
Learn More & Join Trial
Clinical Trial of the Dual Vector Base Editor for the Treatment of the CHD3-R1025W Mutation EARLY_PHASE1 To evaluate the safety, tolerability and preliminary efficacy study of a si...
Show More Location
Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial